Literature DB >> 23423607

[Modern diagnostic tools for esophageal pathologies].

A Kandulski1, P Malfertheiner, J Weigt.   

Abstract

Modern functional laboratories provide various techniques for the evaluation of esophageal diseases. For proton pump inhibitor (PPI) refractory reflux symptoms the differentiation of non-erosive gastroesophageal reflux disease and functional heartburn is essential for the choice of further treatment. The differentiation of the two clinical entities is based on functional diagnostic methods, such as catheter-based and catheter-free pH measurement as well as combined pH measurement and intraluminal impedance. Combined pH measurement and impedance monitoring detects individual reflux episodes and permits the diagnosis of additional functional esophageal diseases, such as supragastric belching. The technical innovation of high resolution manometry has led to a better understanding of esophageal pathophysiology and motility disorders and resulted in a new classification system of esophageal motility disorders (Chicago classification). The diagnosis of achalasia by high resolution manometry differentiates three distinct subtypes which has a direct therapeutic impact on the clinical management.

Entities:  

Mesh:

Year:  2013        PMID: 23423607     DOI: 10.1007/s00108-012-3183-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  42 in total

1.  High-resolution manometry in evaluation of factors responsible for fundoplication failure.

Authors:  Roger P Tatum; Renato V Soares; Edgar Figueredo; Brant K Oelschlager; Carlos A Pellegrini
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

2.  Value of preoperative esophageal function studies before laparoscopic antireflux surgery.

Authors:  Walter W Chan; Laura R Haroian; C Prakash Gyawali
Journal:  Surg Endosc       Date:  2011-03-18       Impact factor: 4.584

Review 3.  Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography.

Authors:  A J Bredenoord; M Fox; P J Kahrilas; J E Pandolfino; W Schwizer; A J P M Smout
Journal:  Neurogastroenterol Motil       Date:  2012-03       Impact factor: 3.598

4.  Outcomes of treatment for achalasia depend on manometric subtype.

Authors:  Wout O Rohof; Renato Salvador; Vito Annese; Stanislas Bruley des Varannes; Stanislas Chaussade; Mario Costantini; J Ignasi Elizalde; Marianne Gaudric; André J Smout; Jan Tack; Olivier R Busch; Giovanni Zaninotto; Guy E Boeckxstaens
Journal:  Gastroenterology       Date:  2012-12-28       Impact factor: 22.682

Review 5.  Functional esophageal disorders.

Authors:  Jean Paul Galmiche; Ray E Clouse; András Bálint; Ian J Cook; Peter J Kahrilas; William G Paterson; Andre J P M Smout
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies.

Authors:  R Sweis; M Fox; R Anggiansah; A Anggiansah; K Basavaraju; R Canavan; T Wong
Journal:  Aliment Pharmacol Ther       Date:  2008-12-19       Impact factor: 8.171

Review 7.  Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment.

Authors:  Ronnie Fass
Journal:  J Clin Gastroenterol       Date:  2007 May-Jun       Impact factor: 3.062

8.  Validation of the reflux disease questionnaire for an Italian population of patients with gastroesophageal reflux disease.

Authors:  Fabio Pace; Pamela Scarlata; Valentina Casini; Piercarlo Sarzi-Puttini; Gabriele Bianchi Porro
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 2.566

9.  Achalasia: a new clinically relevant classification by high-resolution manometry.

Authors:  John E Pandolfino; Monika A Kwiatek; Thomas Nealis; William Bulsiewicz; Jennifer Post; Peter J Kahrilas
Journal:  Gastroenterology       Date:  2008-07-22       Impact factor: 22.682

10.  Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.

Authors:  E Savarino; D Pohl; P Zentilin; P Dulbecco; G Sammito; L Sconfienza; S Vigneri; G Camerini; R Tutuian; V Savarino
Journal:  Gut       Date:  2009-05-20       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.